Clinical Trial Update: Cyclophosphamide With Biochemical Progression During Lenalidomide-Dexamethasone Treatment for Relapsed/Refractory Multiple Myeloma (MM) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating cyclophosphamide in combination with lenalidomide and dexamethasone for relapsed/refractory multiple myeloma with biochemical progres…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• DEXAMETHASONE (Dexamethasone)
• Lenalidomide (lenalidomide)

Snippet

Sponsor: Fondazione EMN Italy Onlus | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED